Literature DB >> 6874877

Clones of MRC-C cells may be superior to the parent line for the culture of 229E-like strains of human respiratory coronavirus.

R J Phillpotts.   

Abstract

A clone was selected from the MRC-C continuous heteroploid cell line which was significantly better than MRC-C for the culture of human respiratory coronavirus (HCV) 229E, strain LP. Such clones could prove generally useful for the isolation of HCV-229E from clinical specimens, and for the propagation and assay of laboratory adapted strains.

Entities:  

Mesh：

Year:  1983        PMID： 6874877      PMCID： PMC7119661          DOI： 10.1016/0166-0934(83)90041-1

Source DB:  PubMed          Journal:  J Virol Methods        ISSN： 0166-0934            Impact factor:   2.014


  4 in total

1.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

2.  Marked instability of character of cloned epithelial cells.

Authors:  H P Schnebli; M Burger; F F Strasser; E Suter
Journal:  Exp Cell Biol       Date:  1977

3.  Variation in the susceptibility of BHK populations and cloned cell lines to three strains of foot-and-mouth disease virus.

Authors:  J B Clarke; R E Spier
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

4.  Isolation of rhinoviruses and coronaviruses from 38 colds in adults.

Authors:  H E Larson; S E Reed; D A Tyrrell
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327
  4 in total
  15 in total

1.  Nucleotide sequence of the gene encoding the membrane protein of human coronavirus 229 E.

Authors:  T Raabe; S G Siddell
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection.

Authors:  K A Callow
Journal:  J Hyg (Lond)       Date:  1985-08

3.  Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers.

Authors:  P G Higgins; R J Phillpotts; G M Scott; J Wallace; L L Bernhardt; D A Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

4.  The time course of the immune response to experimental coronavirus infection of man.

Authors:  K A Callow; H F Parry; M Sergeant; D A Tyrrell
Journal:  Epidemiol Infect       Date:  1990-10       Impact factor: 2.451

5.  Pathogenicity for humans of human rhinovirus type 2 mutants resistant to or dependent on chalcone Ro 09-0410.

Authors:  S R Yasin; W al-Nakib; D A Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

6.  Impact of respiratory virus infection in patients with chronic chest disease.

Authors:  M J Wiselka; J Kent; J B Cookson; K G Nicholson
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

7.  Signs and symptoms in common colds.

Authors:  D A Tyrrell; S Cohen; J E Schlarb
Journal:  Epidemiol Infect       Date:  1993-08       Impact factor: 2.451

8.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children.

Authors:  S L Johnston; P K Pattemore; G Sanderson; S Smith; F Lampe; L Josephs; P Symington; S O'Toole; S H Myint; D A Tyrrell
Journal:  BMJ       Date:  1995-05-13

9.  Detection of human coronavirus 229E in nasal washings using RNA:RNA hybridisation.

Authors:  S Myint; S Siddell; D Tyrrell
Journal:  J Med Virol       Date:  1989-09       Impact factor: 2.327

10.  Detection of rhinovirus RNA in nasal epithelial cells by in situ hybridization.

Authors:  C Bruce; P Chadwick; W al-Nakib
Journal:  J Virol Methods       Date:  1990-10       Impact factor: 2.014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.